COMPASS Pathways Plc (CMPS) — LONDON & NEW YORK, September 02, 2026--Compass Pathways, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, has been named a 2026 Fierce 50 Breakthrough honoree by Fierce Pharma, Fierce Biotech and Fierce Healthcare. The Fierce 50 recognizes 50 individuals and organizations driving advancements in medicine, fostering innovation and shaping the future of biopharma and healthcare.
Source: Business Wire — read the full announcement there.
See our COMPASS Pathways company profile for background, links, and more COMPASS Pathways news.